Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy

被引:7
作者
Hosaka, F [1 ]
Shiga, T [1 ]
Sakomura, Y [1 ]
Wakaumi, M [1 ]
Matsuda, N [1 ]
Kasanuki, H [1 ]
机构
[1] Tokyo Womens Med Univ, Heart Inst Japan, Dept Cardiol, Shinjuku Ku, Tokyo 1628666, Japan
关键词
amiodarone; arrhythmogenic right ventricular cardiomyopathy distribution; concentration;
D O I
10.1007/s003800200012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The tissue distribution of amiodarone and desethylamiodarone, its active metabolite, was examined in an autopsied case, an 85-year-old man, with arrhythmogenic right ventricular cardiomyopathy (ARVC) who had been receiving amiodarone for 4 years. High concentrations of amiodarone. a very highly lipophilic compound, were found in adipose and bone marrow tissues. Despite a low dose (100 mg daily), the concentrations of amiodarone were higher in the epicardial fat (570.4 mug/g) and in the right atrium (165.3 mug/g) than previously reported in patients with other cardiac diseases. The ratios of amiodarone/desethylamiodarone concentrations in both tissues were > 1. This unique distribution demonstrates the involvement of histological characteristics of ARVC, such as fatty replacement of myocardium. We anticipate that a low dose of amiodarone would be effective in preventing arrhythmia in some patients with ARVC.
引用
收藏
页码:154 / 156
页数:3
相关论文
共 46 条
  • [21] Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: Is it reasonable?
    Kanoupakis, EM
    Kochiadakis, GE
    Manios, EG
    Igoumenidis, NE
    Mavrakis, HE
    Vardas, PE
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2003, 8 (01) : 19 - 26
  • [22] Pharmacological Cardioversion of Recent Onset Atrial Fibrillation with Intravenous Amiodarone in Patients Receiving Long-Term Amiodarone Therapy: Is It Reasonable?
    Emmanuel M. Kanoupakis
    George E. Kochiadakis
    Emmanuel G. Manios
    Nikolaos E. Igoumenidis
    Hercules E. Mavrakis
    Panos E. Vardas
    Journal of Interventional Cardiac Electrophysiology, 2003, 8 : 19 - 26
  • [23] Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy
    Rankin, Stephen
    Elder, Douglas H.
    Ogston, Simon
    George, Jacob
    Lang, Chim C.
    Choy, Anna Maria
    CARDIOVASCULAR THERAPEUTICS, 2017, 35 (03)
  • [24] HEPATIC DYSFUNCTION AND NEUROTOXICITY IN A PATIENT RECEIVING LONG-TERM LOW-DOSE AMIODARONE THERAPY
    Arkun, Alp
    Van Deusen, Shawn K.
    Grau, Timothy
    Birkhahn, Robert H.
    JOURNAL OF EMERGENCY MEDICINE, 2010, 38 (03) : 337 - 339
  • [25] Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: A case report
    Hiroki Oikawa
    Chihaya Maesawa
    Ryo Sato
    Kanta Oikawa
    Hiroyuki Yamada
    Seizo Oriso
    Sadahide Ono
    Akiko Yashima-Abo
    Koji Kotani
    Kazuyuki Suzuki
    Tomoyuki Masuda
    World Journal of Gastroenterology, 2005, (34) : 5394 - 5397
  • [26] Long-term comparative trial of sotalol, metoprolol and amiodarone in patients with severe heart failure and malignant ventricular arrhythmia
    Belenkov, YN
    Sangonova, DF
    Ageev, FT
    Mareev, VY
    KARDIOLOGIYA, 1996, 36 (12) : 37 - 48
  • [27] Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: A case report
    Oikawa, Hiroki
    Maesawa, Chihaya
    Sato, Ryo
    Oikawa, Kanta
    Yamada, Hiroyuki
    Oriso, Seizo
    Ono, Sadahide
    Yashima-Abo, Akiko
    Kotani, Koji
    Suzuki, Kazuyuki
    Masuda, Tomoyuki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (34) : 5394 - 5397
  • [28] Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease
    Kovoor, P
    Eipper, V
    Byth, K
    Cooper, MJ
    Uther, JB
    Ross, DL
    EUROPEAN HEART JOURNAL, 1999, 20 (05) : 364 - 374
  • [29] Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease
    Qin, Dingxin
    Leef, George
    Alam, Mian Bilal
    Rattan, Rohit
    Munir, Mohamad Bilal
    Patel, Divyang
    Khattak, Furqan
    Adelstein, Evan
    Jain, Sandeep K.
    Saba, Samir
    CARDIOLOGY JOURNAL, 2015, 22 (06) : 622 - 629
  • [30] Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis
    F. Bogazzi
    E. Dell’Unto
    M. L. Tanda
    L. Tomisti
    C. Cosci
    F. Aghini-Lombardi
    C. Sardella
    A. Pinchera
    L. Bartalena
    E. Martino
    Journal of Endocrinological Investigation, 2006, 29 : 694 - 699